Update on Herpes Zoster Immunization (Recorded Webinar)

Herpes zoster (shingles) affects approximately 30% to 50% of Canadian adults.

Two herpes zoster (HZ) vaccines are now available in Canada to reduce the incidence of shingles and post herpetic neuralgia. Increase your understanding of herpes zoster and its serious complications, and learn about the differences between the live-attenuated and inactivated adjuvanted HZ vaccines available to protect adults from shingles.

Arm yourself with the knowledge you need to provide patient-centred recommendations and build your injection practice!

This program has been sponsored by an educational grant from Merck Canada.

Disclosure: Please review the disclosures within the recording of the webinar.